We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Bradley Maron

Bradley A. Maron MD

Associate Professor of Medicine, Harvard Medical School; Co-Director, Pulmonary Vascular Disease Center, VA Boston Healthcare System, Boston, Massachusetts

Dr. Bradley Maron is an Associate Professor of Medicine at Harvard Medical School and Co-Director of the Pulmonary Vascular Disease Center at the VA Boston Healthcare System. Epidemiology work from his group has helped to shape understanding of cardiopulmonary hemodynamic ranges associated with clinical in pulmonary hypertension. His laboratory focus involves utilizing network medicine and systems biology to identified critical cysteinyl thiol redox switches that promote vascular fibrosis in pulmonary arterial hypertension. Dr. Maron has co-authored more than 130 peer-reviewed scientific manuscripts. His work is funded by the National Institutes of Health, American Heart Association, Cardiovascular Medical Research and Education Foundation, and the Scleroderma Foundation. He is a member of the American Society of Clinical Investigation and recipient of the Eleanor and Miles Shore Scholar in Medicine, McKenzie Chartable Family Master Clinician Award, and other distinguished academic honors.

Disclosures

Dr. Maron reports the following:
  • Funding sources: 1R01HL155096, R01HL153502, R01HL139613-01, R21HL145420, Cardiovascular Medical Research Education Foundation; McKenzie Family Charitable Trust.
  • Conflicts of Interest: co-inventor on US patent 9,605,047, US pending patent PCT/US2019/059890, and provisional patent applications 62475955 and 029672; and is a member of the steering committee for a research grant supported by Actelion Pharmaceuticals.